TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2024

A Randomized, Double-Blind, Phase 3 Safety and Efficacy Study of Ridinilazole Versus Vancomycin for Treatment of Clostridioides difficile Infection: Clinical Outcomes With Microbiome and Metabolome Correlates of Response.

Pablo C Okhuysen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.